Guangzhou Customs has created – and patented – the country’s first “mobile integrated biosafety shelter”. It went into operation at Guangzhou’s Baiyun International Airport on May 6. The shelter, which is built as a collection of pod-like cabins, each shaped like a typical prefab office space, has been established under the “National Key R&D Program” of the Ministry of Science and Technology. The cabins can be added to or subtracted from, like Lego building blocks, for different usage scenarios across a wide range of port types, whether they be at sea, land or airports. They will also be widely used at medical institutions and isolated observation points.
The square cabin is 12 meters long, 3.5 meters wide, and 3 meters high. It is pressurized, and reaches biosafety level 2 (P2) or higher. Customs officers can safely carry out quarantine work such as epidemiological investigation, sample collection, case observation, and rapid testing in the cabin, processing five passengers at a time. SCN.
Guangzhou Pharmaceuticals Group, a major player in China’s drugs industry, has announced it is investing US$200 million into establishing its international headquarters in Macau.
The company’s chairman, Li Chuyuan, gave a speech today at a launch ceremony attended by many of Macau’s political and business elite. He pointed out that the new venture “Combines the resources of Guangdong and Macau together in an innovative collaboration of systems and mechanisms.”
The company is being positioned as the “external window” of Guangzhou Pharmaceuticals’ business, to “accelerate the group’s internationalization”. Sources suggested its focus will be on markets in the Lusophone community of Portuguese-speaking countries.
Macau’s Secretary for Finance and Economy, Lei Wai Nong, said the project will support the Guangdong-Macau Chinese Medicine Science and Technology Industrial Park. Guangzhou Pharmaceuticals is expected to introduce new drug research and development there.
We have been tracking news related to the liberalization of the elderly-care market in Guangdong for some time. Now, the provincial government has issued some guidelines that look promising for investors, although the emphasis is clearly on non-profit organizations first.
Shenzhen Capital Group, a state-owned venture capital firm, announcedlast week that the company has launched its debut healthcare fund to raise over RMB2 billion (US$291 million).
The target amount of the first round of fundraising is RMB800 million ($116 million). The debut healthcare fund – Shenzhen Hongtu Healthcare Private Equity Fund – has already secured capital commitments from state-owned Shenzhen City Guidance Fund Investment, PingAn Real Estate Investment, ICBC, Chinese private equity firm Before Capital, and Kunpeng Capital.
Foshan’s Shunde district has signed a contract with the University of Bradford from the UK to establish a biotech and healthcare innovation center at Shunde’s Sanlongwan hi-tech zone.
The China-UK iBridge project aims to develop technologies to tackle neuro diseases for the elderly, such as Alzheimer’s and Parkinson’s. Shunde currently has more than 600 biotech and medical equipment companies.
Fancy living in one of the nine Greater Bay Area cities, but worried about the costs of expatriate education and healthcare? Worry no more – if you are a Talent from one of the two SARs, that is.
Zhuhai’s Municipal Human Resources and Social Security Bureau has released a plan to give talented individuals (talents) from Hong Kong and Macau access to local education and healthcare. The plan aims at establishing all-rounded social insurance and public services for talents from the two SARs by next year. Moreover, it proposes to grant the same pension benefits as locals, and do away with the need for employment permits.
Other incentives offered to talents from Hong Kong and Macau are already well known: the Zhuhai government provides subsidies and invests in incubators. It would seem that the city is focused on attracting only the brightest, however: those with a post-graduate degree.
Foshan’s Chancheng district has officially launched a “blockchain based vaccine safety management platform”, the first of its kind in Guangdong. Once implemented, all 750,000 doses of vaccine in the district will be under “full supervision”, from production to cold chain transportation, warehousing, circulation, reservation, vaccination and post-injection follow-up.
According to the Foshan Health Bureau, the platform will strengthen supervision of healthcare practitioners while offering convenience to patients. With the blockchain technology, a tracking code will be given to each vaccine and each of its movements from the factory to the warehouse to the clinic will be duly recorded, monitored and shared in real-time, via mobile devices. Prospective patients will be able to make appointments and submit enquiries online.
China’s largest commercial property developer, Dalian Wanda, has won the auction of a 133,252 square meter land parcel in Guangzhou’s Huangpu district for RMB1.34 billion, on which it will build a major international-quality healthcare project.
The local government required the winning bidder to partner with a US News Top 20 medical group on the project.
Wanda’s acquisition of the site was part of its plan to venture into the healthcare sector. At the beginning of the year, the group’s chairman, Wang Jianlin, who was once China’s richest man before Beijing’s deleveraging campaign forced to Wanda to shed over US$9 billion worth of assets over the past year, said that Wanda would focus on building a “top hospital” . The project would combine medical and healthcare services as well as commercial facilities and medical training facilities.
Last September, Wanda signed an agreement with the University of Pittsburg Medical Center to build a general hospital and introduce its management and systems into China.